Literature DB >> 22813097

Hyperbaric oxygen therapy for the management of chronic wounds.

Ferdi Oztürk1, Aylin Türel Ermertcan, Işil Inanir.   

Abstract

Wound healing is actually a complex, precisely coordinated interaction between inflammatory cells and mediators, establishing significant overlap between the phases of wound healing. Chronic wounds are defined as wounds that do not follow the well-defined stepwise process of physiologic healing. The true incidence and economic impact of chronic wounds are difficult to assess because of the wide range of causative diseases and available treatment options. Despite multiple simultaneous and sequential therapeutic approaches, chronic wounds are highly resistant to treatment and are often indolent or even slowly progressive. Hyperbaric oxygen therapy (HBOT) has been explored as a treatment modality for chronic wounds because of its potential to promote healing and reduce bioburden in the wound bed. Multiple potential beneficial effects for wound healing have been demonstrated in various laboratory studies and experimental animal models. In this manuscript, HBOT, its mechanism of action, adverse effects and usage in diabetic and nondiabetic chronic wounds have been reviewed.

Entities:  

Mesh:

Year:  2012        PMID: 22813097     DOI: 10.3109/15569527.2012.705407

Source DB:  PubMed          Journal:  Cutan Ocul Toxicol        ISSN: 1556-9527            Impact factor:   1.820


  4 in total

1.  Hyperbaric Oxygen Therapy and Oxygen Compatibility of Skin and Wound Care Products.

Authors:  Stéphanie F Bernatchez; Joseph Tucker; Gwenael Chiffoleau
Journal:  Adv Wound Care (New Rochelle)       Date:  2017-11-01       Impact factor: 4.730

2.  Antibacterial and Anti-inflammatory Activity of Extracts and Major Constituents Derived from Stachytarpheta indica Linn. Leaves and Their Potential Implications for Wound Healing.

Authors:  Vajira Asela Agampodi; Peter Katavic; Christopher Collet; Trudi Collet
Journal:  Appl Biochem Biotechnol       Date:  2022-07-29       Impact factor: 3.094

3.  Reactive oxygen species prevent imiquimod-induced psoriatic dermatitis through enhancing regulatory T cell function.

Authors:  Hyung-Ran Kim; Anbok Lee; Eun-Jeong Choi; Min-Pyo Hong; Jeong-Hae Kie; Woosung Lim; Hyeon Kook Lee; Byung-In Moon; Ju-Young Seoh
Journal:  PLoS One       Date:  2014-03-07       Impact factor: 3.240

4.  Non-thermal atmospheric plasma ameliorates imiquimod-induced psoriasis-like skin inflammation in mice through inhibition of immune responses and up-regulation of PD-L1 expression.

Authors:  Yun Sang Lee; Myung-Hoon Lee; Hang-Jun Kim; Ho-Ryun Won; Chul-Ho Kim
Journal:  Sci Rep       Date:  2017-11-14       Impact factor: 4.379

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.